About Wamika Pharmaceuticals
Wamika Pharmaceuticals was a Healthcare company based in Ambala (India) founded in 2001 by Naveen Garg and Parveen Garg. Manufacturer of generic injectables, ointment, and syrup. It operates on a Traditional Pharmaceuticals model. Its Indian entity Wamika Pharmaceuticals Pvt. Ltd. reported revenue of ₹2.46 Cr. The company is recorded as dissolved. Wamika Pharmaceuticals offers products and services including Wamika Pharmaceuticals Platform. Its focus areas include Traditional Pharmaceuticals, Generics, Companies and Diversified.
Company details
Wamika Pharmaceuticals, based in Ambala, focuses on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic injectables, ointment, and syrup. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Ambala, India
- Founders Naveen Garg, Parveen Garg
- SectorsHealthcare
- Website wamikapharma.com
- Legal Name Wamika Pharmaceuticals Pvt. Ltd.
- Date of Incorporation 23 May, 2001
- Jurisdiction Haryana, India
- Annual Revenue₹2.46 Cr
FY 2023 · -6% YoY
- Net Profit₹5.9 Lakh
FY 2023 · 2% margin
- EBITDA₹17.6 Lakh
FY 2023 · 7% margin
Associated legal entities of Wamika Pharmaceuticals
Wamika Pharmaceuticals operates through Wamika Pharmaceuticals Pvt. Ltd. (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Wamika Pharmaceuticals Pvt. Ltd. CIN U24233HR2001PTC034685 | Active | 23 May 2001 | ₹2.5 Cr | 1 | View details |
Products & Services of Wamika Pharmaceuticals
Wamika Pharmaceuticals offers a comprehensive portfolio of products and services, including Wamika Pharmaceuticals Platform.
Manufacturer of generic injectables, ointment, and syrup
Board of directors of Wamika Pharmaceuticals Pvt. Ltd. (Wamika Pharmaceuticals)
Wamika Pharmaceuticals Pvt. Ltd. is the primary company behind Wamika Pharmaceuticals. The board of Wamika Pharmaceuticals Pvt. Ltd. currently has 1 director; the longest-serving is Naveen Kumar Garg, appointed in 2001. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Naveen Kumar Garg DIN 00827533 | Director | 23 May 2001 | 25 yrs 5 mo | Wamika Pharmaceuticals Pvt. Ltd. |
People of Wamika Pharmaceuticals
2 people are tracked at Wamika Pharmaceuticals (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & Director | Leadership | |
Parveen Garg | Co-Founder & Director | Leadership |
Complete people profiles for Wamika Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Wamika Pharmaceuticals
Figures of Wamika Pharmaceuticals Pvt. Ltd., the primary company behind Wamika Pharmaceuticals, for FY 2023. Revenue was ₹2.46 Cr (-6% year on year). Net profit was ₹5.9 Lakh (2% margin). EBITDA was ₹17.6 Lakh (7% margin). Revenue has grown at a compounded annual rate of +12% over three years and +13% over five years.
- ₹2.46 CrRevenue · FY 2023 · -6% YoY
- ₹5.9 LakhNet profit · 2% margin
- ₹17.6 LakhEBITDA · 7% margin
- ₹6.6 LakhPaid-up capital
- +12%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Wamika Pharmaceuticals Pvt. Ltd. are on its company page.
Detailed financial statements for Wamika Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Wamika Pharmaceuticals
Wamika Pharmaceuticals was founded in 2001.
Wamika Pharmaceuticals is headquartered in Ambala, India. It is registered at Ambala, Haryana, India.
The primary company behind Wamika Pharmaceuticals, Wamika Pharmaceuticals Pvt. Ltd., reported revenue of ₹2.46 Cr for FY 2023, down 6% year on year.
Wamika Pharmaceuticals, based in Ambala, focuses on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic injectables, ointment, and syrup. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Wamika Pharmaceuticals offers Wamika Pharmaceuticals Platform.
Wamika Pharmaceuticals operates through Wamika Pharmaceuticals Pvt. Ltd..
The legal entities of Wamika Pharmaceuticals currently have 1 director, including Naveen Kumar Garg.